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healthy study partlclpants were analyzed by whole-blood aggregometry. Platelet aggre- 
gation was determined by the increase in impedance across paired electrodes in 
response to the aggregatory agents collagen and ADP, respectively. For CV patients, 
these data were regarded for medication. Blood samples from healthy study participants 
were studied after addition of ACE inhibitors in different dosage titrations. Results: As 
the central flnding, platelet aggregation was attenuated ex viva by captopril and ramipril 
as well as by ASA and clopidogrel. While decrease in collagen-induced platelet aggrega- 
tion was significant with captopril (24%: P=O.O2) and ramipril (29%; P=O.O3), an adverse 
increase was seen with enalapril (11%; PcO.05). Following collagen induction, platelet 
aggregation decreased by 23% (PcO.01) with ASA and with ASAiclopidogrel by 35% 
(P=O.O4). After ADP induction, inhibition with ASA!clopidogrel was 85% (PcO.Ol), with 
ASA 19% (P=O.O3) and with captoprll there was a trend of inhibition (27%; P=O.l4); no 
significant antithrombotic effect was seen with ramiprrl or enalapril. In vitro, there was no 
significant change of platelet aggregation after addition of specific ACE Inhibitors. Con- 
clusions: Our findlngs provide direct evidence for ACE inhibitors to decrease platelet 
aggregation ex viva A differential anti-aggregatory profile of ACE inhibitors may explain 
different effects on CV events as observed in large clinical trials. Failure of effects in vitro 
suggests that the antithrombotic effect is not due to direct interaction between ACE inhib- 
itors and thrombocytes. 
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1132-120 Fish Oil Attenuates Ox-Low-Density Lipoprotein 
Induced Expression of Adhesion Molecules in Human 
Coronary Artery Endothelial Cells 
Honaiianq Chen, Dayuan Li. Tom Saldeen, Jawahar L. Mehta, University of Arkansas for 
Medical Sciences, Llttle Rock, AR. Central Arkansas Veterans Healthcare System, Little 
Rock, AR 
Background: A number of studies have suggested antt-atherosclerotic effects of fish/ 
fish oil. Uptake of oxidized low-density lipoprotein (ox-LDL) by endothelial cells is an 
early step in atherogenesis. Ox-LDL upregulates expression of adhesion molecules. 
such as P-selectin and intracellular adhesion molecule-l (ICAM-1). We hypothesized 
that fish oil components may reduce ox-LDL-mediated expression of adhesion mole- 
cules. 
Materials & Methods: Cultured human coronary artery endothelial cells (fourth ganera- 
tion) were incubated with ox-LDL (40&ml) for 24 hrs. Parallel groups of cells were pre- 
treated with docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) (IO and 50 
PM), the tw major components of fish oil, for overnight before incubation with ox-LDL. 
Another group of cells was treated with the protein kinase B (PKB) inhibitor wortmannin 
(100 nM) along with DHA (50 pM). 
Results: Ox-LDL markedly increased the expression of P-selectin and ICAM-I (both pro- 
tern and mRNA) in HCAECs, enhanced the adherence of monocytes to the cultured 
endothelail cells, and inhlbited the activity of PKB. Both EPA and DHA decreased ox- 
LDL-induced upregulation of P-se&tin and ICAM-I expression and adherence of mono- 
cytes, and increased the activity of PKB (all PqO.02 vs. ox-LDL alone, n=6). The effects 
of 50 pfv’ concentration were rnwe pronounced than the effects of IO @l (P<O.O5). 
Import&tly, the PKB inhibitor wortmann~n attenuated the effects of DHA (PcO.05). 
Conclusions: The present study shows that both EPA and DHA attenuate the ox-LDL- 
induced expression of adhesion molecules and the adherence of monocytes to the 
endothelial cells These effect of EPA and DHA are mediated by modulation of PKB 
activity. These effects of EPA’DHA may underlie the anti-atherosclerotic effects of fish/ 
fish oils. 
1132-121 Angiotensin Receptor Type 1 (AT,) Independent Growth 
Effects of Intracellular Angiotensin II (Ang II) in Cardiac 
Myocytes 
Ralesh Kumar, Sandhya Sanghi, Kenneth M. Baker, David E. Dostal, The Texas A & M 
University System Health Science Center, Temple, TX 
Background: Cardiac remodeling and growth can be elicited through autocrine and 
paracrine actions of Ang II, vra binding to the AT, plasma membrane receptor. An intrac- 
rim? role for Ang II has been postulated; however, no direct growth related evidence sup- 
ports this postulate. We present evidence of growth promoting effects of intracellular Ang 
II I” rat neonatal cardiac myocytes. Others and we have previously demonstrated AT, 
lkke intracellular Ang II bindlng sites on hepatocyte nuclear envelopes. 
Methods: Neonatal rat ventricular myocytes were infected with the Tet-off adenovirus 
coding for Ang II peptide (Ad_Ang II). The effect on growth was studied by sH-Leucine 
incorporation after 72 h of infection in the presence and absence of the cell permeable 
and impermeable Ang II receptor antagonists, losartan and candesartan, respectively. 
Intracellular and extracellular Ang II levels were measured by a competitive ELISA 
assay. 
Results: In myocytes infected with Ad_Ang II (72 h), the levels of intracellular Ang II 
were increased by 72.4 % (99 + 6 vs 58 * 15 PM) compared to control virus (Ad-Cow) 
An increase of 132 % (378 r 70 vs 162 * 39 PM) in extracellular Ang II levels was also 
observed, possibly due to a positlve-feedback loop. In Ad_Ang II treated myocytes, there 
was a 63.7 f 39.6 % increase in 3H-Leucine incorporation, which was not blocked by 
losartan and candesartan, indicating that this effect was mediated through mechanisms 
independent of an AT, like plasma membrane or nuclear receptor. Conditidned medium 
obtained from Ang II expressing cells stimulated growth in naive cells by 11.1 + 3.5 %. 
which was completely blocked by losartan and candesartan. 
Conclusion: Intracellular Ang II promotes cardiac myocyte growth through mechanisms 
independent of plasma membrane AT, receptor activation and secreted growth factors. 
This observation may represent a second level of control for Ang II mediated growth and 
provides a potentially important target for therapeutic inten ention. 
1132-122 Genetic Determinants of Left Ventricular Mass: The 
Role of Beta-l Adrenoceptor Variation in Normal, 
Athletic, and Disease Populations 
TOW Stanton, John R. Payne, Hugh E. Montgomery, Graham Watt, Anna F. Dominlczak. 
Alan G. Jardine, John M. Connell, University of Glasgow, Glasgow, United Kingdom, 
Unwersity College London, London, United Kingdom 
Background: Left ventricular (LV) mass is an extremely strong predrctor of cardiovascu- 
lar morbidity and mortality in the general population. The beta-l adrenoceptor (Bl AR) is 
a key cell surface signalling protein expressed in the heart. As beta-blocker therapy is 
cardloprotective and myocyie growth is stimulated by receptor agonists. it is possible that 
variation in the receptor gene may affect LV mass.The gene of the Bl AR has two known 
functlonal polymorphisms; one of these confers an amino acid change at position 389 
from glycine (G) to arginine (C). The arginlne-form of the receptor (C) has been demon- 
strated to have far greater actlvrty when bound by agonist and also increased GTP bind- 
ing. Methods & Results: We therefore examined the relationship between this variation 
in the BlAR gene and the effect on LV mass in 3 different populations.The first com- 
prised 2280 healthy individuals with ECG-derived LV mass. No significant difference was 
found between LV mass and BIAR genotype. The second population comprised 207 
healthy males who underwent a IO week cardiovascular training programme. LV mass 
was determined by MRI at the start and end of the training period. No difference was 
found for the increase in LV mass when analysed for BIAR genotype. The third popula- 
bon comprised 249 patients with renal disease with echocardiographically determined LV 
mass. There was a highly significant difference in LV mass between the GG group when 
compared to the other 2 groups, CG:GG pqO.05 and CC:GG pcO.01. There were no sig- 
nificant difference in blood pressure measurments, ejection fraction or age between gen- 
otypes.Omining those on renal replacement therapy, beta-blockers or ACE inhibitors did 
not diminish the strength of the association. 
Conclusion: GenetIc variation at the Bl AR locus is of greater importance in defining LV 
mass in pathologkxl circumstances. 
1132-123 Effects of Vascular Endothelial Growth Factor on 
Proliferation and Differentiation of Embryonic Stem 
Cells 
Yu Chen Yinke Yang, Qingen Ke, Jamal S. Rana, James P. Morgan, Yang-Fu Xrao, -3 
Harvard Medical School, Boston, MA 
Our previous study showed that compared to transplantation of embryonic stern cells 
(ESCs) alone in infarcted hearts, improvement of cardiac function was significantly 
greater in post-infarcted mice transplanted with ESCs overexpressing vascular endothe- 
lial growth factor (VEGF). Accumulated evidence demonstrates that VEGF affects 
embryonic development and stimulates vascular growth. In the present study, we investi- 
gated the effects of VEGF, in vitro, on ESC proliferation and differentiation in the pres- 
ence or absence of leukemia inhibitory factor (LIF). ESC proliferation was measured by 
the MTr method (Cell proliferation kit I, sigma). Compared to the control group, 20 ng/ml 
VEGF did not affect proliferation of ESCs cultured in the presence of LIF (1000 units/ml) 
at 6 and 11 days. However, in the absence of LIF, 20 ngiml VEGF significantly enhanced 
ESC proliferation. The numbers of cells were significantly increased by 45 -t 5% (n = 7) 
and by 79 * 7% (n = 7) at 6 and 11 days in culture, respectively. Similar results were 
observed in the expenments of ESCs transfected with VEGF cDNA (phVEGF165). In 
addition, the hanging drops method was used to evaluate differentiation of ESCs cultured 
in the absence of LIF. The portion of ESCs that differentiated to cardiac a-myow heavy 
chain @-MHC) positive cells was sorted by flow cytometry. Compared to VEGF- 
untreated ESCs. 20 @ml VEGF increased the number of a-MHC positive cells by 84 f 
8% (n = 3) at 11 days in culture. In ESCs transfected with VEGF cDNA. the number of a- 
MHC posltwe cells was increased by 52 * 7% (n = 3) at 11 days in culture Moreover, 
WeStern blot analysis further confirmed that in the absence of LIF, the amwnt ofa-MHC 
protein was significantly increased in ESCs treated with 20 ngiml VEGF or in ESCs 
transfected with VEGF-cDNA. Our data demonstrate that VEGF did not affect orollfera- 
tlon of ESCs cultured in the presence of LIF, but stimulated proliferation and dlfferentia- 
tion of ESCs cultured in the absence of LIF. The information of the VEGF-Induced 
significant increase in differentiation of ESCs to cardiac a-MHC positive cells is probably 
important for future cell therapy to regenerate injured myocardium. 
1132-124 Location of Mutation in the KCNQI Gene Does Not 
Influence Outcome of Long QT Syndrome Patients 
Woiciech Zareba, Arthur J. Moss, Gloria Sheu, Elizabeth S. Kaufman, Jennifer L 
Robinson, Mark L. Andrew, Elizabeth Carroll, for International LQTS Registry 
University of Rochester, Rochester, NY 
Background. Recent data showed that long QT syncrome (LQTS) patrents with mu:ations 
in the pore region of HERG (LQT2) gene have significantly higher risk of cardiac events 
than patients with mutations in non-pore region. The aim of this study was to determine 
whether there IS an association between location of mutations in the KCNQI gene and 
cardiac events in LQTI patients. 
Methods. Study population consisted of 216 LQTI patients with KCNQI gene mutation. 
Demographic, clinical. and follow-up informabon was compared among patients with dif- 
ferent location of KCNQI mutations defined as: prs-pore region including N-terminus (I- 
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278). pore region (279-354), and post-pore region including C-terminus (>354). Cardiac 
events observed during follow-up from bilth till age of last contact 01 age 40 years were 
defined as syncope, cardiac arrest, or sudden death. 
Results. There were 117 (54%) LQTl patients with pre-pore mutations, 84 (39%) 
patients with pore mutations, and 15 (7%) patients with post-pore mutation. Table shows 
a comparison of clinical, ECG and cardiac events data between three groups: no slgnifi- 
cant differences were observed between groups. 
Conclusions. There are no significant differences in clinical presentation, ECG parame- 
ters, and cardiac events among LQTl patients with different locatlon of KCNQl mutation. 
These findings indicate that other modulation factors than location of mutation influence 
variable pewtrance of the gene in LQTI patients. 
sarcolemma and T-tubules. Conclusions: PLM modulates cardiac myocyte contractility 
in part by altering NCXl function. We also speculate that overexpression of PLM may 
play a role in the contractile abnormalities obsewed in post infarction cardiac myocyies. 
LQTI Patients by Mutation Locatmn 
Females 
Pre-Pore 
(Il=ll7) 
56 (48%) 
Pore Post-Pore (n=i 5) 
(n&l) 
49 9 (60%) 
(56%) 
Mean QTc (ms) 
Cardiac Events 
491 489 508 
57 (50%) 33 4 (31%) 
(39%) 
Mean age at 1 st cardiac event (years) 11 12 12 
1132-125 Connexin 43 Expression Is Elevated in Human Chronic 
Atrial Fibrillation Related to Coronary Heart Disease 
Rivaz A. Kaba, Steven R. Coppen, Emmanuel DuPont, Anthony C. De Souza, John R. 
Pepper, Nicholas J. Severs, National Heart & Lung Institute, Imperial College, London, 
United Kingdom 
Background: Atrial fibrillation (AF), a cardiac arrhythmia arising from multiple atrial re- 
entrant circuits, has a tendency to become chronic and persistent with time. Such chro- 
nicity of AF is associated with electrophysiological remodeling of the myocardium. As 
gap junctions are responsible for cell-cell electrical coupling. the present study assessed 
remodeling of the three main cardiac myocyte gap junctional proteins, connexins 43, 40 
and 45, in patients with chronic AF (> six months) and underlying coronary heart disease. 
Methods: Right atrial appendage samples were collected from ten patients undergoing 
coronary by-pass surgery. Pm-operatively six of the patients were in sinus rhythm (SR) 
and four in chronic AF. Samples were immediately frozen in liquid nitrogen for analysis 
by western blotting and immunocytochemistry. Quantitative western blotting was under- 
taken for connexins 43 and 40. lmmunolabeled connexins 43,40 and 45 were examined 
by confocal microscopy. Results: Connexin43 protein levels were significantly elevated 
(~~0.03) in patients with chronic AF compared to those in SR. whereas connexin40 pro- 
tein levels did not differ between the two groups (p=O.62). In patients with SR, the immu- 
nolabeled gap junctions were seen predommantly at the intercalated discs of atrial 
myocytes, with only little labeling at the lateral membranes: in patients with AF, the gap 
junctions appeared to be distributed more evenly throughout the cell membranes. Con- 
clusions We have demonstrated that in patients with underlying coronary heart disease, 
the level of connexin43 in chronic AF is elevated compared to that in SR; connexin40 lev- 
els remain unaltered. This connexin43 remodeling may contribute to the resistance of 
converting AF to SR with time. Although altered connexin43 expression has previously 
been implicated in human ventricular arrhythmias, this study suggests a wider involve- 
ment of this connexin to include arrhythmias originating in the atria. The present data do 
not conform to those reported from some animal models of AF, emphasizing the need for 
caution in extrapolating from these models to the human setting. 
1132-126 Phospholemman Modulates Sodium-Calcium Exchange 
in Adult Rat Myocytes 
Anwer Qureshi, Xue-Qian Zhang, Joseph Y. Cheung, Weis Center for Research, 
Danville, PA, Geisinger Medical Center, Danville, PA 
Background: The physiological role of phospholemman (PLM) is largely unknown 
except that PLM phosphorylation in response to adrenergic stimulation parallels a posi- 
tive inotropic effect and that expression of PLM is increased 2.fold in post-infarction rat 
myocytes. We previously demonstrated that PLM overexpression in adult rat myocytes 
results in altered contractility and cytosolic calcium concentration transients. This change 
in contractility mimics that seen in postinfarction rat myocytes, where the sodium-calcium 
exchanger (NCXl) activity has been shown to be depressed. We tested the hypothesis 
that PLM effects on myocardial contractility is due to modulation of NCXl function. Meth- 
ods: Cardiac myocytes were isolated from the left ventricular free wall and septum of 
male Sprague-Dawley rats. Recombinant replication-deficient adenovws (Adv) express- 
ing either green fluorescent protein (GFP) alone, or GFP and PLM, or GFP and NCXl 
were constructed and used to infect myocytes. After 72 hours, myocyte contraction was 
measured in medium containing 0.6 mM and 5 mM calcium. Caffeine induced contrac- 
ture were performed to evaluate forward NCXl function. Whole cell patch clamp record- 
ings were performed to measure reverse sodium-calcium exchange current and action 
potential. Results: Half time of relaxation from caffeine-induced contracture, an estimate 
of forward NCXl activity, was prolonged 1 .tl fold in myocyies expressing PLM when 
compared to control myocytes expressing GFP alone. Reverse NCXI current was signif- 
icantly lower in PLM myocytes, particularly at mole positive voltages. At 5 mM extracellu- 
lar calcium the deoressed contraction amplitude in PLM mvocvtes were increased 
towards normal by co-expression of NCXl. At 0.6 mM extracellular calcium the supranor- 
mal contraction amplitudes in PLM infected cardiac myocytes were reduced by NCXl co- 
expression. lmmunofluorescence demonstrated co-localization of PLM and NCXl to the 
1132-127 A DNA Microarray Survey for Gene Expression Changes 
in Atrial Fibrillation 
Ankur Kamik, Adam Saltman, Kenny Ye, E. Vie Tselentakis, Glenn Gaudette, Anil 
Dhundale. State University of New York at Stony Brook Health Sciences Center, Stony 
Brook, NY, University of Massachusetfs Memorial Medical Center, Worcester, MA 
Background: Atrial fibrillation (AF) is believed to arise from very small reentrant circuits 
but the underlying electrophysiological and molecular mechanisms remain unclear. We 
sought to identify a set of genes that are differentially expressed in AF. 
Methods: DIscarded atrial appendage tissue was obtained from 6 patients with AF (AFl- 
6) and 6 normal sinus rhythm patients (NSI-6), all undergoing coronary artery bypass 
graft surgety. Four pools were made; NSPl (NSI-3). NSP2 (NS4-6), AFPl (AFl-3), and 
AFPP (AF4-6). RNA was extracted and analyzed using Affymetrix U95 subA GeneChips 
containing 12,625 genes. Samples were analyzed individually (AFI-6) or as “pools” 
where equal amounts of RNA were mixed prior to labeling and hybridization on the 
GeneChip. This experimental pooling technique allowed us to minimize inter-individual 
variation yet maximize differences that appeared solely as a function of AF. 
Results: A total of 6,893 genes had detectable expression. HERG mRNA was down reg- 
ulated bv 33% in AF oatlents (w0.05). whereas there was an UD reaulation in mRNA of 
ADAM 1; (37%). Calpain 1 (18%), Troponin C (30%), and lntegrinn; (79%) (pa.05). 
Conclusions: Our oreliminarv findinos indicate that AF is accomoanled bv alterations in _ _ , 
mRNA levels of several genes, including those that code for ion channels (HERG), pro- 
tems involved in atrial structure (Troponin C and Integrinal), and mediators of inflamma- 
tion 01 C$+ induced atrial remodeling (ADAM 15 and Calpain I). This research may 
uftimately lead to identification of potential diagnostic and therapeutic targets for AF. 
1132-l 28 Alpha,,-Adrenergic Receptor Polymorphism Influences 
Baroreflex Sensitivity and Nonsustained Ventricular 
Tachycardia in Idiopathic Dilated Cardiomyopathy 
Cmzia Forlea Pietro Guida, Sandra Sorrentino, Massimo lacoviello, Vwana De Luca. 
Roberta Romito. Federica Troisi, Andrea Manghisi. Paolo Rizzon, Manavittoria Pitzalis, 
Bad, Italy 
Altered baroreflex sensitivity (BRS) has previously shown to identify patients (pts) with 
chronic heart failure (CHF) at risk for non-sustained ventricular tachycardia (NSVT). 
Since u- and ~adrenergic receptor (AR) are involved in either the pathophysiology of 
CHF and in the autonomic control of heart rate, we evaluated whether a- ando-AR poly- 
morphic variants are associated with NSVT and/or lower spontaneous BRS. 
One hundred and fifty-two unrelated pts (age 49*14 years, 116 males) with DCM (WHO 
criteria), while receiving optimal treatment, underwent a 24-hour ECG recording, and 
were genotyped for the Ser49Gly and Arg389Gly polymorphisms of the pl-AR. the 5 
leader cistron ArglgCys, ArglGGly, Gln27Glu, and Thr164lle polymorphisms of the p2- 
AR, the Trp64Arg polymorphism of the p3-AR, and the Arg492Cys polymorphism of the 
ala-AR. The allelic vanants were characterised on the basis of PCR amplified DNA 
using RFLP analysis. In 77 pts it was possible to evaluate spontaneous BRS (msec/mm 
Hg) by wng the sequence method. 
We found a significant association between the Arg492Cys polymorphism of theala-AR 
and NSVT (Table). Moreover, pts carrying homozygosity for the Arg492 allele had signif- 
icantly lower BRS in comparison with those who were heterozygous and homoxygous for 
Cys492. No significant differences were found among the other genotypes in terms of 
NSVT and BRS. 
In conclusion, our data show that homozygous genotype for Arg492 is associated with 
depressed BRS and a higher occurrence of NSVT in DCM. 
Number 
NYHA class 
Ejection Fraction (%) 
NSVT (%) 
??RS (msec/mm Hg) 
HomoArg Hetero HomoCys p 
34 79 39 
l&O.8 l&O.7 1.9eO.6 NS 
36*11 37&l 0 36~12 NS 
50 23 36 0.015 
6.5i2.7 11.9*9.0 15.4*9.7 0.022 
1132-129 Delayed lschemic Preconditioning Enhances Bcl-2 
Expression and Regulates the Mitochondrial 
Permeability Transition Pore 
Raiesh G. Katare, Shire Sasaguri, Hitonori Maeda. Ryoko Suzuki, Kochi Medical School, 
Nankoku, Japan 
Background : The second window of protection (SWOP), beginning from 24 hours and 
lasting up to 72 hours following the brief episodes of coronary artery occlusions has been 
well demonstrated, but the exact mechanism of this protection still remains COntrOVSrSiSl. 
Here we have demonstrated the role of mitochondrial permeability transition pore, a non- 
specific pore in the inner membrane of the mitochondria, in mediating this protection. 
Methods and Results :Ischemic Preconditioning (IP) was induced in rats by four 3 min- 
utes left coronary artery occlusions, each separated by 10 minutes of reperfusion on day 
1. 30 minutes of lschemia and 120 minutes of repedusion on day 2 revealed, less area of 
myocardial infarction (Ml) in the IP group (15.32% to 45.6%, SWOP vs. sham), well 
maintained cardiac functions (heart rate, rate pressure product and dp/dt), well main- 
tained myocardial ATP (P < 0.03), less tissue water content (73.2% to 90.6%, SWOP vs 
sham), increased expression of 6~1.2, prevention of mitochondrial swelling and cyto- 
